BioCentury
ARTICLE | Company News

Shin Nippon Biomedical spins out Satsuma

January 6, 2017 10:34 PM UTC

Shin Nippon spun out Satsuma Pharmaceuticals Inc. (San Francisco, Calif.). The newco said that it plans to begin a clinical trial of migraine candidate STS101 "in about a year." STS101 is a dry-powder...